Boundless Bio, Inc. (BOLD) vs Eloxx Pharmaceuticals, Inc. (ELOX)

A side-by-side comparison of Boundless Bio, Inc. and Eloxx Pharmaceuticals, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

BOLD

Boundless Bio, Inc.

$58M

$2.60HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT

ELOX

Eloxx Pharmaceuticals, Inc.

$51M

$14.75HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT

Total return — BOLD vs ELOX

growth of $100 · dividends reinvested · last 1y

BOLD +85.7% (+85.7%/yr)ELOX +40.0% (+40.0%/yr)BOLD compounded faster over this window

BOLD ELOX

Metrics side by side

Total return (annualized)

Metric	BOLD	ELOX
Total return (1Y)	110.63%	N/A

ELOX is an index fund, so valuation, profitability, and per-company growth metrics don't apply — the head-to-head here is total return (price plus reinvested dividends).

Go deeper

Full BOLD analysis Full ELOX analysis Interactive comparison tool

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.